Back

CRISPR-Cas9-based gene editing of human mesenchymal stromal cells to improve the outcome of cell therapy

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Basic Science Cardiac ePosters Gene Therapy, Cell Therapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Mr Yeshai Schary

Tel Aviv University, Tel Aviv (Israel)

110 More presentations in this session

Presentation thumbnail
Elimination of senescent cells targeting Senescence associated glycoprotein (SAGP) improved the ageing-associated diseases and extended the lifespan
Doctor M. Suda (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Single-cell RNA sequencing of human fetal epicardium reveals novel markers and regulators of EMT
Mr T. Streef (Leiden, NL)
Abstract Slides
Presentation thumbnail
Genome-wide association study identifies 18 new susceptibility variants loci associated with Brugada Syndrome
Associate Professor J. Barc (Nantes, FR)
Abstract Slides
Presentation thumbnail
Mutations in CHMP4C cause dilated cardiomyopathy via dysregulation of autophagy
Doctor N. Zhou (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Disruption of the architecture of the junctional sarcoplasmic reticulum in recessive catecholaminergic polymorphic ventricular tachycardia is caused by the er-shaping proteins reep5 and climp63
Doctor R. Bongianino (Pavia, IT)
Abstract Slides

Access the full session

Session thumbnail
Basic Science Cardiac ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Extracellular vesicles from mesenchymal stromal cells combined with tissue engineering for myocardial repair
29 June 2021
thumbnail
Congress Presentation
Gene/base editing as therapy for common cardiovascular disorders
31 August 2024
thumbnail
Congress Presentation
Single-cell sequencing of the healthy and diseased heart reveals Ckap4 as a new modulator of fibroblasts activation.
21 April 2018
thumbnail
Congress Presentation
Cardiovascular complications of chimeric antigen receptor (CAR)-t cell therapy: insights from a regional cardio-oncology program
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources